Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

AbCellera Initiates Dosing Of Participants In A Phase 1 Clinical Trial Of ABCL635; Co. Initiated A Phase 1 Clinical Trial Of ABCL575, Which Is Being Developed For The Treatment Of Moderate-To-Severe Atopic Dermatitis

Author: Benzinga Newsdesk | August 07, 2025 04:11pm

Posted In: ABCL

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist